Centre Hospitalier de Versailles
Le Chesnay, 78150, France
NCT Number: NCT03166969
Retrospective study, single-center, on 171 patients, presented a cryptogenic TIA and Minor stroke.
This study objective is to determine profitability of Holter 21 days for screening paroxystic ACFA / flutter in cryptogenic TIA/Minor stroke, and identify the predictive factors of discovery a paroxystic ACFA on Holter 21 days. Clinical and échocardiographics factors, and brain imaging (scanner and MRI) will be analyzed.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Le Chesnay, 78150, France
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: Day 21
Atrial fibrillation >= 30 secondes
Versailles Hospital
Other
Acronym: HOLTER-21J
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.